Mark Frohlich - Chief Executive Officer @ Indapta Therapeutics

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

Mark Frohlich is the CEO at Indapta Therapeutics. Mark Frohlich attended University of California, San Francisco.

Number of Current Jobs

is the

Chief Executive Officer

Number of Current Board & Advisor Roles

is the

Board Member

Hub Name	CB Rank (Hub)
Leaps by Bayer Portfolio Companies	82,315
Red Cedar Ventures Portfolio Companies	73,976
West Coast Biopharma Companies	24,062
Pontifax Portfolio Companies	91,605
Vertex Ventures Portfolio Companies	33,486
Cancer Prevention and Research Institute of Texas Portfolio Companies	89,988
Western US Biopharma Companies	20,854

There is no recent news or activity for this profile.